Navigation Links
Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Date:11/12/2007

che, and nausea. Children taking KALETRA may sometimes get a skin rash. Other side effects may occur.

Pancreatitis and liver problems, which can be fatal, have been reported in patients receiving KALETRA. Patients should tell their doctor if they have nausea, vomiting, or abdominal pain, which may be signs of pancreatitis, or if they have or have had liver disease such as Hepatitis B or C.

Some patients have had large increases in triglycerides and cholesterol. Changes in body fat have been seen in some patients taking anti-HIV therapy. The long-term health effects of these conditions are not known at this time. Diabetes and high blood sugar have occurred in patients taking protease inhibitors such as KALETRA.

Some patients with hemophilia have increased bleeding with protease inhibitors.

The effects of KALETRA on pregnant women or their unborn babies are not known. Mothers taking KALETRA should not breast-feed.

All strengths of KALETRA tablets should be swallowed whole and not chewed, broken, or crushed.

KALETRA tablets should be stored at room temperature. Exposure of this product to high humidity outside the pharmacy container for longer than 2 weeks is not recommended.

Refrigerated KALETRA oral solution remains stable until the expiration date printed on the label. If stored at room temperature up to 77F (25C), KALETRA oral solution should be used within 2 months.

Avoid exposure to excessive heat. For full prescribing information visit http://www.kaletra.com.

Abbott and HIV

Abbott has been a leader in HIV/AIDS research since the early years of the epidemic. In 1985, the company developed the first licensed test to detect HIV antibodies in the blood and remains a leader in HIV diagnostics. Abbott retroviral and hepatitis tests are used to screen more than half of the world's donated blood supply. Abbott has developed two protease inhibitors for the treat
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Access MediQuip, ... implant management company, announced today that it has expanded ... of the nation's largest health benefits companies, with more ... and approximately 66 million individuals served through its subsidiaries. ... national surgical implant management program agreement back in 2008. ...
(Date:5/21/2013)... Beginning May 21st, 2013, DTP Sales & Service ... newest in digital recording technology, to the hands of ... anyone looking to get the most from technology professional ... is expected to have revolutionary options and impeccable design. ... features and highlights: ,      ...
(Date:5/21/2013)... May 21, 2013 Tools4ever, the market ... made its Self Service Reset Password Management (SSRPM) suitable ... can now use the service on mobile systems i.e.; ... users can easily reset their Windows passwords anywhere, anytime. ... questions correctly, the user may then reset his or ...
(Date:5/21/2013)... Alan Mozes HealthDay Reporter , , MONDAY, ... used by millions of people with chronic obstructive ... cardiovascular complications among older patients, a new large ... patients over age 65 who are prescribed long-acting ... beta-agonists (such as Serevent). Both medications are commonly ...
(Date:5/21/2013)... The surgical management of non-small cell lung cancer (NSCLC) ... of the patient, according to a new study., "In ... Stage II NSCLC is surgery," said researcher Jayanth Adusumalli, ... Nebraska. "In our study of more than 1,200,000 patients ... 2000 and 2010, we found statistically significant racial disparities ...
Breaking Medicine News(10 mins):Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 2Health News:Access MediQuip and WellPoint Renew and Expand National Contract for Implantable Medical Devices 3Health News:DTP Sales & Service Announces Upcoming Availability Of Philips Pocket Memo 8000 Series 2Health News:Tools4ever’s password reset software ready for BYOD 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3
... Senior Vice President Brent Rickles Explains How to Protect ... ... Scottsdale, Ariz. (PRWEB) September 10, 2008 ... security management, launches a customer http://www.lumension.com/request_form.jsp?id=142756&rpLeadSourceId=1 [podcast ...
... recently launched to the online scene to cater to people who ... moments. Pampering one,s self is a most deserved treat for ... ... 10, 2008 -- Premised upon totally hassle-free virtual shopping, www.personalcaredeals.com ...
... Medicare; identifies best options and guides people through the process ... ... Ill. (Vocus) September 10, 2008 -- http://www.allsup.com/ [Allsup] ... individuals with disabilities with the introduction of http://www.allsup.com/Medicare-Advisor.aspx ...
... DSM Pharmaceutical Products,(DPP) announced today the ... of,record for marketing services. This relationship, in ... DSM business group and its three business,units: ... Pharmaceuticals, Inc., DSM Pharmaceutical Products offers ...
... private equity investors have increasingly targeted nursing homes ... anecdotal evidence that these deals led to worsened ... under increased federal scrutiny. , But according ... premature. Private equity purchases of nursing homesmany of ...
... C14-UBT are the most commonly used non-invasive tests of ... depend also on the prevalence of H. pylori ... tests depend also on the prevalence of H. pylori ... higher sensitivity and lower specificity. There are reports suggesting that ...
Cached Medicine News:Health News:Lumension Security Launches Podcast On Application Whitelisting: Keep The Bad Guys Out - Let The Good Guys In 2Health News:Lumension Security Launches Podcast On Application Whitelisting: Keep The Bad Guys Out - Let The Good Guys In 3Health News:Lumension Security Launches Podcast On Application Whitelisting: Keep The Bad Guys Out - Let The Good Guys In 4Health News:A One-Stop Online Shop For Personal Pampering Needs 2Health News:A One-Stop Online Shop For Personal Pampering Needs 3Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 2Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 3Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 4Health News:Allsup's New Medicare Advisor Program Helps People with Disabilities Make Sound Healthcare Coverage Decisions 5Health News:DSM Pharmaceutical Products Announces the Appointment of That's Nice LLC as Agency of Record for Marketing 2Health News:DSM Pharmaceutical Products Announces the Appointment of That's Nice LLC as Agency of Record for Marketing 3Health News:Private equity companies purchase nursing homes, but care does not suffer 2Health News:Private equity companies purchase nursing homes, but care does not suffer 3
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May 21, ... and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... online the positive Phase 2a study results of dupilumab ... an investigational monoclonal antibody targeting the alpha subunit of ... of both IL-4 and IL-13, drivers of Th2 (Type ...
(Date:5/21/2013)... 2013  Healthcare organizations expanding into emerging markets like ... , India and ... shortcuts.  This is proving particularly challenging, considering the current ... change the dialogue around BRIC, as it is now ... building regional partnerships to build a sustainable business. ...
(Date:5/21/2013)... 2013 U.S. spending on specialty prescription drugs ... as cancer, multiple sclerosis and rheumatoid arthritis — is ... 2015, according to a forecast released today by Express ... ) "As we see what,s on ... to act so they can continue to offer an ...
Breaking Medicine Technology:Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 2U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 3U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 4U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015 5
... June 2, 2011 As global food insecurity reaches ... how one company can impact this growing crisis. Today, ... 100,000 families globally through a partnership with Heifer International. ... and Company, a leading global pharmaceutical corporation, is also ...
... Siemens Healthcare (NYSE: SI) will ... workflow management solutions at the Society for Imaging Informatics ... 2011, (booth 825) in the Gaylord National Resort and ... facing increased pressure to provide faster, more accurate diagnoses ...
Cached Medicine Technology:Elanco Announces Commitment to Fight World Hunger 2Elanco Announces Commitment to Fight World Hunger 3At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties 2At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties 3At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: